Marc Hilmi

Also affiliated with Université de Versailles Saint-Quentin-en-Yvelines, Institut Curie

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Muscle Loss During First‐Line Chemotherapy Impairs Survival in Advanced Pancreatic Cancer Despite Adapted Physical Activity”.

Muscle Loss During First‐Line Chemotherapy Impairs Survival in Advanced Pancreatic Cancer Despite Adapted Physical Activity

Journal of Cachexia, Sarcopenia and Muscle(2025)10.1002/jcsm.13595

N/A

0.312DataRank · unranked

7 citations

Frédéric Pigneur, Marc Hilmi, Aurélien Carnot, Marie‐Line Garcia Larnicol, Dewi Vernerey +6 more

Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II Trial

Research Square(2025)10.21203/rs.3.rs-7334701/v1

N/A

0.214DataRank · unranked

3 citations

Catherine O’Connor, Joanne F. Chou, Marc Hilmi, Zeynep Tarcan, Carly Schwartz +61 more